Heather M. E. Duggan

Author

Also Known As

Duggan, H.M.E., Heather Duggan, Heather M. E. Duggan, Heather M.E. Duggan

Publications

358

Citations

H-Index

Concepts

All Affiliations

Heather M. E. Duggan is an author at AstraZeneca (United Kingdom) specializing in natural sciences, drug discovery, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	328
2	Natural Sciences	3	3	328
3	Biochemistry	3	3	328
4	Chemical Biology	3	3	328
5	Molecular Biology	1	1	45

Heather M. E. Duggan

Publications

355

Citations

H-Index

Page 1

	Year	Citations
Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: The discovery of AZD8055 and AZD2014 Kurt G. Pike, Karine Malagu, Marc Hummersone, Bioorganic & Medicinal Chemistry Letters Molecular DockingMedicinal ChemistryDrug TargetBiochemistryMedicine	2013	204
The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase Karine Malagu, Heather M. E. Duggan, Keith Menear, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryDrug TargetBiochemistryNatural Sciences	2009	79
DNA-Dependent Protein Kinase (DNA-PK) Inhibitors. Synthesis and Biological Activity of Quinolin-4-one and Pyridopyrimidin-4-one Surrogates for the Chromen-4-one Chemotype Céline Cano, Olivier Barbeau, C. L. Bailey, Journal of Medicinal Chemistry Chromen-4-one ChemotypeTarget EnzymeDrug TargetBioorganic ChemistryMolecular Biology	2010	45
Synthesis of 5/7-, 5/8- and 5/9-bicyclic lactam templates as constraints for external β-turns Heather M. E. Duggan, Peter B. Hitchcock, Douglas W. Young Organic & Biomolecular Chemistry	2005	27

Page 1